How Duke is Improving Outcomes and Navigating Reimbursement For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is a device therapy that works... Read More
Barostim's Role in Heart Failure Management: Q&A with Dr. Debbie Rinde-Hoffman Debbie A. Rinde-Hoffman, MD, FACC is an Advanced Heart Failure and Transplant Cardiologist and the Vice Chief HVI... Read More